MINDACT: 70-gene signature test as guidance for breast cancer treatment
1 Oct 2020
MINDACT: 70-gene signature test as guidance for breast cancer treatment
Management of infection risk to myeloma patients during the COVID pandemic
Lenalidomide combination for multiple myeloma
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer
ESMO 2020 melanoma roundup
PROFound trial and other recent updates in prostate cancer
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma
Managing multiple myeloma in a COVID-19 world
ESMO 2020 renal roundup
Exon 20 insertions in NSCLC - ESMO 2020
ESMO 2020: Lung cancer latest
Highlights from ESMO 2020